Victory Capital Management, Inc. 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-03 12:34 pm Unchanged | 2020-12-31 | 13G | Fate Therapeutics, Inc. FATE | Victory Capital Management, Inc. | 2,091,280 2.400% | 0 (Unchanged) | Filing |
| 2021-02-03 10:51 am Sale | 2020-12-31 | 13G | Fate Therapeutics, Inc. FATE | Victory Capital Management, Inc. | 2,091,280 2.400% | -2,137,874 (-50.55%) | Filing |